Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
84.31B | 77.99B | 77.30B | 73.42B | 74.19B | Gross Profit |
26.88B | 32.88B | 31.62B | 32.20B | 30.93B | EBIT |
18.23B | 17.01B | 15.93B | 15.22B | 14.45B | EBITDA |
24.51B | 23.48B | 22.11B | 22.17B | 21.42B | Net Income Common Stockholders |
12.40B | 12.13B | 10.85B | 10.66B | 10.52B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
3.51B | 3.16B | 3.26B | 3.19B | 3.10B | Total Assets |
118.27B | 115.57B | 119.65B | 118.61B | 112.18B | Total Debt |
10.00M | 43.00M | 106.00M | 198.00M | 308.00M | Net Debt |
-3.50B | -3.12B | -3.16B | -3.00B | -2.79B | Total Liabilities |
19.07B | 18.09B | 18.53B | 18.42B | 17.80B | Stockholders Equity |
96.54B | 95.09B | 98.88B | 96.42B | 91.03B |
Cash Flow | Free Cash Flow | |||
9.53B | 1.76B | 6.66B | 10.49B | 9.57B | Operating Cash Flow |
15.09B | 11.33B | 14.64B | 18.77B | 19.07B | Investing Cash Flow |
-3.57B | 4.91B | -3.94B | -13.82B | -13.11B | Financing Cash Flow |
-11.17B | -16.35B | -10.63B | -4.85B | -6.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥10.43T | 20.00 | 3.91% | 7.57% | 6.30% | ||
80 Outperform | $13.39T | 13.14 | 9.84% | 3.50% | 2.47% | -20.86% | |
76 Outperform | ¥232.17B | 18.94 | 12.86% | 2.59% | 8.11% | 6.49% | |
73 Outperform | $519.80B | 25.63 | 14.78% | <0.01% | 14.76% | 0.69% | |
70 Outperform | $9.20T | 14.36 | 13.04% | 3.01% | 2.85% | 12.63% | |
66 Neutral | $372.12B | 27.96 | 15.57% | 1.95% | 6.94% | -14.06% | |
62 Neutral | $11.93B | 10.60 | -7.51% | 3.00% | 7.40% | -8.09% |